News & Updates

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023

In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023
Dynapenia ups risks of falls, fractures in women with obesity
Dynapenia ups risks of falls, fractures in women with obesity
16 Feb 2023 byStephen Padilla

Reduced muscle strength (dynapenia) is associated with a higher risk of leg and ankle fractures in women with obesity, as shown in a study. Dynapenia also negates the protective effects of obesity on fractures of the wrist, arm, hip, spine, and other bones, thus increasing the risk of falls.

Dynapenia ups risks of falls, fractures in women with obesity
16 Feb 2023
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
15 Feb 2023

Treatment with intravitreal aflibercept in patients with nonproliferative diabetic retinopathy but without centre-involved diabetic macular edema appears to slow disease progression and reduce the risk of developing vision-threatening complications but fall short of improving visual acuity, according to a study.

Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
15 Feb 2023